Development of health biotechnology in developing countries: Can private-sector players be the prime movers?-Reference-Cited by-同舟云学术

Development of health biotechnology in developing countries: Can private-sector players be the prime movers?

Published:2012-11 Issue:6 Volume:30 Page:1589-1601
ISSN:0734-9750
Container-title:Biotechnology Advances
language:en
Short-container-title:Biotechnology Advances

Author:

Abuduxike Gulifeiya,Aljunid Syed Mohamed

Publisher

Elsevier BV

Subject

Biotechnology,Bioengineering,Applied Microbiology and Biotechnology

Reference95 articles.

1. Country focus: Indian Biotech Bazaar: a swot analysis;Abhishek;Biotechnol J,2007

2. The Brazilian vaccine manufacturers' perspective and its current status;Akira;Biologicals,2009

3. Korean experience. Presentation and contribution on case study on South Korea as part of the Malaysia AMI-STI project;Bong,2010

4. Reinventing global health: the role of science, technology, and innovation. Millennium Project;Calestous;Lancet,2005

5. Innovation: applying knowledge in development. UN Millennium Project, Task Force on Science, Technology and Innovation. United Nations Development Programme;Calestous,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The influence of the public sector in promoting digital transformation during the pandemic;Annals of Business Administrative Science;2023-08-15

2. Bench-to-bedside: Translational development landscape of biotechnology in healthcare;Health Sciences Review;2023-06

3. India’s Biotech Emergence: A Critical Political Economy Analysis;East Asian Science, Technology and Society: An International Journal;2022-05-16

4. A brief overview of global biotechnology;Biotechnology & Biotechnological Equipment;2021-02-07

5. Insights for the future of health system partnerships in low- and middle-income countries: a systematic literature review;BMC Health Services Research;2020-06-22